Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Scripps Research Institute | 8 |
| 2 | American Regent Inc | 6 |
| 3 | Tanabe Pharma Corp | 5 |
| 4 | The University of Texas System | 5 |
| 5 | Ube Corp | 5 |
| 6 | University of Alabama at Birmingham | 5 |
| 7 | La Jolla Pharmaceutical Co | 4 |
| 8 | The University of Texas at Austin | 4 |
| 9 | University of Alabama | 4 |
| 10 | Xrpro Sciences Inc | 4 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 63 |
| 2 | A61P | Therapeutic activity (drug indications) | 29 |
| 3 | Y10S | Cross-reference (legacy) | 19 |
| 4 | C07D | Heterocyclic compounds | 13 |
| 5 | G01N | Investigating / analysing materials | 13 |
| 6 | C07K | Peptides | 9 |
| 7 | B82Y | Nanotechnology | 8 |
| 8 | A61Q | Cosmetics, personal care | 7 |
| 9 | A61M | Devices for introducing media into the body | 4 |
| 10 | C07H | Sugars and derivatives | 4 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Drug-Induced Adverse Reactions | 2 |
| 2 | Contact Dermatitis and Allergies | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Cristobalina Mayorga | Hospital Materno-Infantil | 14 |
| 2 | M. Blanca | Hospital Doctor José Molina Orosa | 13 |
| 3 | Marı́a José Torres | Hospital Doctor José Molina Orosa | 12 |
| 4 | C. Juárez | Hospital Doctor José Molina Orosa | 7 |
| 5 | Hai–Ling Qiao | Zhengzhou University | 6 |
| 6 | E. Pérez | Universidad de Málaga | 4 |
| 7 | Miguel Blanca | Hospital Doctor José Molina Orosa | 4 |
| 8 | Na Gao | Zhengzhou University | 4 |
| 9 | Rafael Suau | Universidad de Málaga | 4 |
| 10 | Xin Tian | Zhengzhou University | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Heterogeneous T cell responses to β-lactam-modified self-structures are observed in penicillin-allergic individuals | 1995 | 191 | Drug-Induced Adverse Reactions |
| Clinical evaluation of Pharmacia CAP System<sup>™</sup> RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy | 2001 | 181 | Asthma and respiratory diseases |
| Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins | 2008 | 176 | Food Allergy and Anaphylaxis Research |
| Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy | 1997 | 166 | Asthma and respiratory diseases |
| The Complex Clinical Picture of β-Lactam Hypersensitivity: Penicillins, Cephalosporins, Monobactams, Carbapenems, and Clavams | 2010 | 141 | Food Allergy and Anaphylaxis Research |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of benzylpenicilloyl group?
Which organizations hold the most patents related to this compound?
What are the main research topics associated with benzylpenicilloyl group?
Who are the most prolific authors in publications about this compound?
What is the scope of patent and publication coverage for benzylpenicilloyl group?